chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Diarrhoea, Dyspnoea, Exposure to SARS-CoV-2
Clinical narrative: Admitted: 10/2/2023 Discharge Date: 10/05/23    PCP Handoff    Recommended Outpatient Testing Follow-up with PCP in 1 to 2 weeks   Results Pending At Discharge    Blood Culture Aerobic/Anaerobic Preliminary result Blood Culture Aerobic/Anaerobic Preliminary result      Clinical Summary   Patient is a 87 y.o. female patient of MD with history of C. Diff, HTN, HFpEF, COPD, CVA, seizure disorder presented to Hospital with cough and shortness of breath.   Acute respiratory failure with hypoxia COPD with possible exacerbation Suspected secondary to recent COVID-19 infection, possible developing secondary lung injury versus secondary bacterial pneumonia. Had COVID symptoms in early September, treated with Paxlovid though was never tested for. COVID (husband tested positive) and did improve with worsening over 5 days prior to admission Treated with medrol dose pack and azithromycin as outpatient without improvement prior to admission. CTPA on admission with interstitial and ground-glass infiltrates are most pronounced in the right lung; bilateral bronchial wall thickening is suggestive of bronchitis. Respiratory PCR,urinary antigens for Legionella and strep pneumo--unremarkable except for COVID. Given levaquin in ED, transitioned to ceftriaxone/azithromycin given higher risk of C. Diff with flouroquinolones.  With patient having diarrhea, discontinued Rocephin and continued azithromycin.  Continued Zithromax to complete the course at discharge. Started decadron for COVID and COPD exacerbation and continued at discharge. Checked O2 requirement prior to discharge.  Qualified for 2 L of oxygen ATC. Patient to follow-up with PCP in 1 to 2 weeks     Recent COVID-19 viral infection Date of onset of symptoms: early September initially, then improved, then 5 days prior to admission Symptoms present on admission: shortness of breath, cough Date of covid positive test: was not tested in early September but treated with Paxlovid due to husband being positive; tested positive on admission 10/2 Vaccination status: vaccinated Imaging: CTPA as above Oxygen requirements on admission: 2L Current oxygen requirements: RA Medical therapy: steroids Consultants following: n/a Anticipated special isolation end date: given unclear timing, remain in isolation 5 additional days   History of recurrent C. Diff infection With prior fulminant infection in Sep 2022, prior FMT Prophylactic PO vancomycin while on antibiotics Patient started having diarrhea in the hospital but stool C. difficile negative   Chronic anemia Baseline hemoglobin 9 to 10 g/dL Admit Hb 9.2> 8.2 most likely due to hemodilution On B12 and iron supplementation   History of CVA With some residual left sided weakness Continue home plavix and statin   Seizure disorder Continue home Keppra   HTN Home Rx: Lisinopril 5 mg daily.  BP was running low.  Discontinued lisinopril.  May restart as an outpatient based on BP readings   HFpEF, chronic Continue home furosemide 20 mg daily
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Haemodilution, Haemoglobin decreased, Hypotension, Hypoxia, Interstitial lung disease
Clinical narrative: Admitted: 10/2/2023 Discharge Date: 10/05/23    PCP Handoff    Recommended Outpatient Testing Follow-up with PCP in 1 to 2 weeks   Results Pending At Discharge    Blood Culture Aerobic/Anaerobic Preliminary result Blood Culture Aerobic/Anaerobic Preliminary result      Clinical Summary   Patient is a 87 y.o. female patient of MD with history of C. Diff, HTN, HFpEF, COPD, CVA, seizure disorder presented to Hospital with cough and shortness of breath.   Acute respiratory failure with hypoxia COPD with possible exacerbation Suspected secondary to recent COVID-19 infection, possible developing secondary lung injury versus secondary bacterial pneumonia. Had COVID symptoms in early September, treated with Paxlovid though was never tested for. COVID (husband tested positive) and did improve with worsening over 5 days prior to admission Treated with medrol dose pack and azithromycin as outpatient without improvement prior to admission. CTPA on admission with interstitial and ground-glass infiltrates are most pronounced in the right lung; bilateral bronchial wall thickening is suggestive of bronchitis. Respiratory PCR,urinary antigens for Legionella and strep pneumo--unremarkable except for COVID. Given levaquin in ED, transitioned to ceftriaxone/azithromycin given higher risk of C. Diff with flouroquinolones.  With patient having diarrhea, discontinued Rocephin and continued azithromycin.  Continued Zithromax to complete the course at discharge. Started decadron for COVID and COPD exacerbation and continued at discharge. Checked O2 requirement prior to discharge.  Qualified for 2 L of oxygen ATC. Patient to follow-up with PCP in 1 to 2 weeks     Recent COVID-19 viral infection Date of onset of symptoms: early September initially, then improved, then 5 days prior to admission Symptoms present on admission: shortness of breath, cough Date of covid positive test: was not tested in early September but treated with Paxlovid due to husband being positive; tested positive on admission 10/2 Vaccination status: vaccinated Imaging: CTPA as above Oxygen requirements on admission: 2L Current oxygen requirements: RA Medical therapy: steroids Consultants following: n/a Anticipated special isolation end date: given unclear timing, remain in isolation 5 additional days   History of recurrent C. Diff infection With prior fulminant infection in Sep 2022, prior FMT Prophylactic PO vancomycin while on antibiotics Patient started having diarrhea in the hospital but stool C. difficile negative   Chronic anemia Baseline hemoglobin 9 to 10 g/dL Admit Hb 9.2> 8.2 most likely due to hemodilution On B12 and iron supplementation   History of CVA With some residual left sided weakness Continue home plavix and statin   Seizure disorder Continue home Keppra   HTN Home Rx: Lisinopril 5 mg daily.  BP was running low.  Discontinued lisinopril.  May restart as an outpatient based on BP readings   HFpEF, chronic Continue home furosemide 20 mg daily
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Legionella test, Lung infiltration, Lung opacity, Malaise, Pneumonia bacterial
Clinical narrative: Admitted: 10/2/2023 Discharge Date: 10/05/23    PCP Handoff    Recommended Outpatient Testing Follow-up with PCP in 1 to 2 weeks   Results Pending At Discharge    Blood Culture Aerobic/Anaerobic Preliminary result Blood Culture Aerobic/Anaerobic Preliminary result      Clinical Summary   Patient is a 87 y.o. female patient of MD with history of C. Diff, HTN, HFpEF, COPD, CVA, seizure disorder presented to Hospital with cough and shortness of breath.   Acute respiratory failure with hypoxia COPD with possible exacerbation Suspected secondary to recent COVID-19 infection, possible developing secondary lung injury versus secondary bacterial pneumonia. Had COVID symptoms in early September, treated with Paxlovid though was never tested for. COVID (husband tested positive) and did improve with worsening over 5 days prior to admission Treated with medrol dose pack and azithromycin as outpatient without improvement prior to admission. CTPA on admission with interstitial and ground-glass infiltrates are most pronounced in the right lung; bilateral bronchial wall thickening is suggestive of bronchitis. Respiratory PCR,urinary antigens for Legionella and strep pneumo--unremarkable except for COVID. Given levaquin in ED, transitioned to ceftriaxone/azithromycin given higher risk of C. Diff with flouroquinolones.  With patient having diarrhea, discontinued Rocephin and continued azithromycin.  Continued Zithromax to complete the course at discharge. Started decadron for COVID and COPD exacerbation and continued at discharge. Checked O2 requirement prior to discharge.  Qualified for 2 L of oxygen ATC. Patient to follow-up with PCP in 1 to 2 weeks     Recent COVID-19 viral infection Date of onset of symptoms: early September initially, then improved, then 5 days prior to admission Symptoms present on admission: shortness of breath, cough Date of covid positive test: was not tested in early September but treated with Paxlovid due to husband being positive; tested positive on admission 10/2 Vaccination status: vaccinated Imaging: CTPA as above Oxygen requirements on admission: 2L Current oxygen requirements: RA Medical therapy: steroids Consultants following: n/a Anticipated special isolation end date: given unclear timing, remain in isolation 5 additional days   History of recurrent C. Diff infection With prior fulminant infection in Sep 2022, prior FMT Prophylactic PO vancomycin while on antibiotics Patient started having diarrhea in the hospital but stool C. difficile negative   Chronic anemia Baseline hemoglobin 9 to 10 g/dL Admit Hb 9.2> 8.2 most likely due to hemodilution On B12 and iron supplementation   History of CVA With some residual left sided weakness Continue home plavix and statin   Seizure disorder Continue home Keppra   HTN Home Rx: Lisinopril 5 mg daily.  BP was running low.  Discontinued lisinopril.  May restart as an outpatient based on BP readings   HFpEF, chronic Continue home furosemide 20 mg daily
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Polymerase chain reaction negative, SARS-CoV-2 test positive, Streptococcus test, Traumatic lung injury, Urine antigen test
Clinical narrative: Admitted: 10/2/2023 Discharge Date: 10/05/23    PCP Handoff    Recommended Outpatient Testing Follow-up with PCP in 1 to 2 weeks   Results Pending At Discharge    Blood Culture Aerobic/Anaerobic Preliminary result Blood Culture Aerobic/Anaerobic Preliminary result      Clinical Summary   Patient is a 87 y.o. female patient of MD with history of C. Diff, HTN, HFpEF, COPD, CVA, seizure disorder presented to Hospital with cough and shortness of breath.   Acute respiratory failure with hypoxia COPD with possible exacerbation Suspected secondary to recent COVID-19 infection, possible developing secondary lung injury versus secondary bacterial pneumonia. Had COVID symptoms in early September, treated with Paxlovid though was never tested for. COVID (husband tested positive) and did improve with worsening over 5 days prior to admission Treated with medrol dose pack and azithromycin as outpatient without improvement prior to admission. CTPA on admission with interstitial and ground-glass infiltrates are most pronounced in the right lung; bilateral bronchial wall thickening is suggestive of bronchitis. Respiratory PCR,urinary antigens for Legionella and strep pneumo--unremarkable except for COVID. Given levaquin in ED, transitioned to ceftriaxone/azithromycin given higher risk of C. Diff with flouroquinolones.  With patient having diarrhea, discontinued Rocephin and continued azithromycin.  Continued Zithromax to complete the course at discharge. Started decadron for COVID and COPD exacerbation and continued at discharge. Checked O2 requirement prior to discharge.  Qualified for 2 L of oxygen ATC. Patient to follow-up with PCP in 1 to 2 weeks     Recent COVID-19 viral infection Date of onset of symptoms: early September initially, then improved, then 5 days prior to admission Symptoms present on admission: shortness of breath, cough Date of covid positive test: was not tested in early September but treated with Paxlovid due to husband being positive; tested positive on admission 10/2 Vaccination status: vaccinated Imaging: CTPA as above Oxygen requirements on admission: 2L Current oxygen requirements: RA Medical therapy: steroids Consultants following: n/a Anticipated special isolation end date: given unclear timing, remain in isolation 5 additional days   History of recurrent C. Diff infection With prior fulminant infection in Sep 2022, prior FMT Prophylactic PO vancomycin while on antibiotics Patient started having diarrhea in the hospital but stool C. difficile negative   Chronic anemia Baseline hemoglobin 9 to 10 g/dL Admit Hb 9.2> 8.2 most likely due to hemodilution On B12 and iron supplementation   History of CVA With some residual left sided weakness Continue home plavix and statin   Seizure disorder Continue home Keppra   HTN Home Rx: Lisinopril 5 mg daily.  BP was running low.  Discontinued lisinopril.  May restart as an outpatient based on BP readings   HFpEF, chronic Continue home furosemide 20 mg daily
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Chills, Pain
Clinical narrative: Severe chills and whole-body aches
Age: 43.0
Sex: F
Vaccine: FLU4
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Lumbar puncture, Magnetic resonance imaging, Paraesthesia
Clinical narrative: Began to experience numbness and tingling in her fingers and toes. Was transferred directly to the hospital where she was diagnosed with Guillain barre syndrome
Age: 55.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Fluad was administered to someone under 65
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal pain, Acute respiratory failure, Arthropod bite, Asthenia, Biopsy skin
Clinical narrative: Patientis a 82 y.o. female with a history of COPD, RA, TIA who was admitted to first hospital 9/19-9/26/23 for COPD exacerbation (discharged on 3L NC), hospital stay complicated by possible Lyme's disease. She was discharged to SNF but family eloped  the pt within six hours due to reported suboptimal care. She represented to second hospital 9/26/2023 with persistent dyspnea and abdominal pain.  Found to have COPD exacerbation and COVID-19 +. Discharged to SNF 10/4/23 in stable condition.    1. COPD Exacerbation: Patient reports COPD normally stable on home regimen but very severe cough/dyspnea PTA. CXR 9/26/23 negative for focal consolidation. Completed doxycycline course. Continued steroid, pulmonary toilet, acapella, scheduled duonebs.  2. COVID Infection: Prior Vaccinations, (+) testing 9/27/23, completed 9 days of Decadron.  3. Acute on Chronic Hypoxic Respiratory Failure: discharged from first hospital to SNF on 9/26/23 on 3L NC. Required up to 4-5 L in p.m. on 10/4/2023 but with the goal O2 sat of greater than 88% patient was able to be weaned down to 3.5 L on discharge. 4. Indeterminate Lyme Serology: Patient with atypical rash on LEs and noted tick contact. Rash has resolved. Lyme serologies and skin biopsy at first hospital were inconclusive, ID at first hospital recommended empiric course of 10 days of doxycycline (completed).   5. Rheumatoid Arthritis: Held home methotrexate. Resume when ok with pts Rheumatology.  6. TIA: Continued home ASA/statin 7. Generalized Weakness: with deconditioning and reduced mobility POA. Patient reports she normally ambulates w/ walker, complains of significant weakness. Therapy recs for SNF.  8. Code Status: DNR-CCA
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Borrelia test, COVID-19, Chest X-ray normal, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Patientis a 82 y.o. female with a history of COPD, RA, TIA who was admitted to first hospital 9/19-9/26/23 for COPD exacerbation (discharged on 3L NC), hospital stay complicated by possible Lyme's disease. She was discharged to SNF but family eloped  the pt within six hours due to reported suboptimal care. She represented to second hospital 9/26/2023 with persistent dyspnea and abdominal pain.  Found to have COPD exacerbation and COVID-19 +. Discharged to SNF 10/4/23 in stable condition.    1. COPD Exacerbation: Patient reports COPD normally stable on home regimen but very severe cough/dyspnea PTA. CXR 9/26/23 negative for focal consolidation. Completed doxycycline course. Continued steroid, pulmonary toilet, acapella, scheduled duonebs.  2. COVID Infection: Prior Vaccinations, (+) testing 9/27/23, completed 9 days of Decadron.  3. Acute on Chronic Hypoxic Respiratory Failure: discharged from first hospital to SNF on 9/26/23 on 3L NC. Required up to 4-5 L in p.m. on 10/4/2023 but with the goal O2 sat of greater than 88% patient was able to be weaned down to 3.5 L on discharge. 4. Indeterminate Lyme Serology: Patient with atypical rash on LEs and noted tick contact. Rash has resolved. Lyme serologies and skin biopsy at first hospital were inconclusive, ID at first hospital recommended empiric course of 10 days of doxycycline (completed).   5. Rheumatoid Arthritis: Held home methotrexate. Resume when ok with pts Rheumatology.  6. TIA: Continued home ASA/statin 7. Generalized Weakness: with deconditioning and reduced mobility POA. Patient reports she normally ambulates w/ walker, complains of significant weakness. Therapy recs for SNF.  8. Code Status: DNR-CCA
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Dyspnoea, Mobility decreased, Physical deconditioning, Rash
Clinical narrative: Patientis a 82 y.o. female with a history of COPD, RA, TIA who was admitted to first hospital 9/19-9/26/23 for COPD exacerbation (discharged on 3L NC), hospital stay complicated by possible Lyme's disease. She was discharged to SNF but family eloped  the pt within six hours due to reported suboptimal care. She represented to second hospital 9/26/2023 with persistent dyspnea and abdominal pain.  Found to have COPD exacerbation and COVID-19 +. Discharged to SNF 10/4/23 in stable condition.    1. COPD Exacerbation: Patient reports COPD normally stable on home regimen but very severe cough/dyspnea PTA. CXR 9/26/23 negative for focal consolidation. Completed doxycycline course. Continued steroid, pulmonary toilet, acapella, scheduled duonebs.  2. COVID Infection: Prior Vaccinations, (+) testing 9/27/23, completed 9 days of Decadron.  3. Acute on Chronic Hypoxic Respiratory Failure: discharged from first hospital to SNF on 9/26/23 on 3L NC. Required up to 4-5 L in p.m. on 10/4/2023 but with the goal O2 sat of greater than 88% patient was able to be weaned down to 3.5 L on discharge. 4. Indeterminate Lyme Serology: Patient with atypical rash on LEs and noted tick contact. Rash has resolved. Lyme serologies and skin biopsy at first hospital were inconclusive, ID at first hospital recommended empiric course of 10 days of doxycycline (completed).   5. Rheumatoid Arthritis: Held home methotrexate. Resume when ok with pts Rheumatology.  6. TIA: Continued home ASA/statin 7. Generalized Weakness: with deconditioning and reduced mobility POA. Patient reports she normally ambulates w/ walker, complains of significant weakness. Therapy recs for SNF.  8. Code Status: DNR-CCA
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patientis a 82 y.o. female with a history of COPD, RA, TIA who was admitted to first hospital 9/19-9/26/23 for COPD exacerbation (discharged on 3L NC), hospital stay complicated by possible Lyme's disease. She was discharged to SNF but family eloped  the pt within six hours due to reported suboptimal care. She represented to second hospital 9/26/2023 with persistent dyspnea and abdominal pain.  Found to have COPD exacerbation and COVID-19 +. Discharged to SNF 10/4/23 in stable condition.    1. COPD Exacerbation: Patient reports COPD normally stable on home regimen but very severe cough/dyspnea PTA. CXR 9/26/23 negative for focal consolidation. Completed doxycycline course. Continued steroid, pulmonary toilet, acapella, scheduled duonebs.  2. COVID Infection: Prior Vaccinations, (+) testing 9/27/23, completed 9 days of Decadron.  3. Acute on Chronic Hypoxic Respiratory Failure: discharged from first hospital to SNF on 9/26/23 on 3L NC. Required up to 4-5 L in p.m. on 10/4/2023 but with the goal O2 sat of greater than 88% patient was able to be weaned down to 3.5 L on discharge. 4. Indeterminate Lyme Serology: Patient with atypical rash on LEs and noted tick contact. Rash has resolved. Lyme serologies and skin biopsy at first hospital were inconclusive, ID at first hospital recommended empiric course of 10 days of doxycycline (completed).   5. Rheumatoid Arthritis: Held home methotrexate. Resume when ok with pts Rheumatology.  6. TIA: Continued home ASA/statin 7. Generalized Weakness: with deconditioning and reduced mobility POA. Patient reports she normally ambulates w/ walker, complains of significant weakness. Therapy recs for SNF.  8. Code Status: DNR-CCA
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Feeling abnormal, Hyperhidrosis, Laboratory test
Clinical narrative: Patient states: "The next day I was in bed feeling like I was having a heart attack. My chest hurt. I was sweating and really feeling bad."  "I did not let anyone know.  By day two, I felt fatigued and with muscle soreness all over, but was feeling better by Day 3."  I did not go to the doctor or the ED.  I told my own doctor about it a while back ago (long after the experience) and he said it might have been myocarditis. "
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Patient states: "The next day I was in bed feeling like I was having a heart attack. My chest hurt. I was sweating and really feeling bad."  "I did not let anyone know.  By day two, I felt fatigued and with muscle soreness all over, but was feeling better by Day 3."  I did not go to the doctor or the ED.  I told my own doctor about it a while back ago (long after the experience) and he said it might have been myocarditis. "
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient recieved the spikevax Moderna vaccine after the use-by-date. Patient was informed and will come get a new vaccine in the next day or 2. No adverse effects were reported.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Expired product administered
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, COVID-19, COVID-19 pneumonia, Chest X-ray normal
Clinical narrative: Patient is a 87 y.o. female patient of, DO with history of hypertension, hyperlipidemia, CKD stage III, colon cancer, generalized osteoarthritis, vitamin D deficiency, history of pulmonary embolism on Eliquis, recent admission from 9/14/2023 to 9/25/2023 for acute metabolic encephalopathy in the setting of hypertensive emergency and possible sepsis presented to Hospital with concern of altered mental status and increased fatigue.  On arrival patient found to have a fever of 101.9 °F with tachycardia and tachypnea.  Patient tested positive for COVID-19 infection.  Patient is being admitted for further management.   COVID-19 pneumonia Acute metabolic encephalopathy 2/2 above resolved Acute hypoxemic respiratory failure secondary to COVID, resolved Patient's CODE STATUS was confirmed with patient's son, patient is DNR CC CXR no acute cardiopulmonary pathology on admission Patient was desatting requiring 2 L of oxygen with admission   Continue respiratory support, keep SPO2 above 94% Continue IV Decadron 6 mg daily Consult ID.  They started Paxlovid.       AKI 2/2 dehydration, resolved Mild hyponatremia, resolved Creatinine elevated 1.51 on presentation with baseline around 1 Start patient on gentle IV fluid hydration   Hypertension Continue amlodipine and metoprolol Holding losartan due to AKI   Hyperlipidemia Continue statin   History of pulmonary embolism Continue Eliquis   Hypophosphatemia Replacement ordered
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Fatigue, Hyperlipidaemia, Hypertensive emergency, Hyponatraemia
Clinical narrative: Patient is a 87 y.o. female patient of, DO with history of hypertension, hyperlipidemia, CKD stage III, colon cancer, generalized osteoarthritis, vitamin D deficiency, history of pulmonary embolism on Eliquis, recent admission from 9/14/2023 to 9/25/2023 for acute metabolic encephalopathy in the setting of hypertensive emergency and possible sepsis presented to Hospital with concern of altered mental status and increased fatigue.  On arrival patient found to have a fever of 101.9 °F with tachycardia and tachypnea.  Patient tested positive for COVID-19 infection.  Patient is being admitted for further management.   COVID-19 pneumonia Acute metabolic encephalopathy 2/2 above resolved Acute hypoxemic respiratory failure secondary to COVID, resolved Patient's CODE STATUS was confirmed with patient's son, patient is DNR CC CXR no acute cardiopulmonary pathology on admission Patient was desatting requiring 2 L of oxygen with admission   Continue respiratory support, keep SPO2 above 94% Continue IV Decadron 6 mg daily Consult ID.  They started Paxlovid.       AKI 2/2 dehydration, resolved Mild hyponatremia, resolved Creatinine elevated 1.51 on presentation with baseline around 1 Start patient on gentle IV fluid hydration   Hypertension Continue amlodipine and metoprolol Holding losartan due to AKI   Hyperlipidemia Continue statin   History of pulmonary embolism Continue Eliquis   Hypophosphatemia Replacement ordered
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Hypophosphataemia, Mental status changes, Metabolic encephalopathy, Oxygen saturation decreased, Pyrexia
Clinical narrative: Patient is a 87 y.o. female patient of, DO with history of hypertension, hyperlipidemia, CKD stage III, colon cancer, generalized osteoarthritis, vitamin D deficiency, history of pulmonary embolism on Eliquis, recent admission from 9/14/2023 to 9/25/2023 for acute metabolic encephalopathy in the setting of hypertensive emergency and possible sepsis presented to Hospital with concern of altered mental status and increased fatigue.  On arrival patient found to have a fever of 101.9 °F with tachycardia and tachypnea.  Patient tested positive for COVID-19 infection.  Patient is being admitted for further management.   COVID-19 pneumonia Acute metabolic encephalopathy 2/2 above resolved Acute hypoxemic respiratory failure secondary to COVID, resolved Patient's CODE STATUS was confirmed with patient's son, patient is DNR CC CXR no acute cardiopulmonary pathology on admission Patient was desatting requiring 2 L of oxygen with admission   Continue respiratory support, keep SPO2 above 94% Continue IV Decadron 6 mg daily Consult ID.  They started Paxlovid.       AKI 2/2 dehydration, resolved Mild hyponatremia, resolved Creatinine elevated 1.51 on presentation with baseline around 1 Start patient on gentle IV fluid hydration   Hypertension Continue amlodipine and metoprolol Holding losartan due to AKI   Hyperlipidemia Continue statin   History of pulmonary embolism Continue Eliquis   Hypophosphatemia Replacement ordered
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tachycardia, Tachypnoea
Clinical narrative: Patient is a 87 y.o. female patient of, DO with history of hypertension, hyperlipidemia, CKD stage III, colon cancer, generalized osteoarthritis, vitamin D deficiency, history of pulmonary embolism on Eliquis, recent admission from 9/14/2023 to 9/25/2023 for acute metabolic encephalopathy in the setting of hypertensive emergency and possible sepsis presented to Hospital with concern of altered mental status and increased fatigue.  On arrival patient found to have a fever of 101.9 °F with tachycardia and tachypnea.  Patient tested positive for COVID-19 infection.  Patient is being admitted for further management.   COVID-19 pneumonia Acute metabolic encephalopathy 2/2 above resolved Acute hypoxemic respiratory failure secondary to COVID, resolved Patient's CODE STATUS was confirmed with patient's son, patient is DNR CC CXR no acute cardiopulmonary pathology on admission Patient was desatting requiring 2 L of oxygen with admission   Continue respiratory support, keep SPO2 above 94% Continue IV Decadron 6 mg daily Consult ID.  They started Paxlovid.       AKI 2/2 dehydration, resolved Mild hyponatremia, resolved Creatinine elevated 1.51 on presentation with baseline around 1 Start patient on gentle IV fluid hydration   Hypertension Continue amlodipine and metoprolol Holding losartan due to AKI   Hyperlipidemia Continue statin   History of pulmonary embolism Continue Eliquis   Hypophosphatemia Replacement ordered
Age: 60.0
Sex: M
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Patient received 2 Fluarix Quad shots this flu season. 8/31/2023 and 11/20/2023
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Somnolence
Clinical narrative: Patient reported the day after vaccination she developed an intense headache and overall fatigue/drowsiness that caused her to become hospitalized for three days before resolution of symptoms
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Breath holding, Musculoskeletal stiffness, Tremor
Clinical narrative: Monitoring post COVID-19 booster vaccination, resident had a seizure at 1130 lasting 45 seconds. Resident was in w/c and started shaking tensed up and held his breath, staff gave resident a sternal rub and he started taking in deep breaths. After about two minutes resident breathing normalized and vitals stable 132/80, 78, 97.5, 15, 97ra.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Limb mass, Peripheral swelling
Clinical narrative: swelling and lump near elbow and some redness. lump lasted for about 6 days
Age: 17.0
Sex: F
Vaccine: HEP
Symptoms: Expired product administered
Clinical narrative: Patient was given Hep B that was expired by less than 24 hours.
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Dizziness, Visual impairment
Clinical narrative: Patient started feeling dizzy and stated that she was seeing black
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient recieved the spikevax Moderna vaccine after the use-by-date. Patient was informed and will come get a new vaccine in the next day or 2. No adverse effects were reported.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Condition aggravated, Confusional state, Gait disturbance, Magnetic resonance imaging head normal, Mental status changes
Clinical narrative: Patient monitored in office for 30 min after administration of vaccinations and tolerated without any symptoms. Left office at 11:15am. Daughter called following morning to report the following: Patient woke up confused this morning. (daughter) noticed patient wasn't in her room this morning when she went to check on her. she found her outside wandering around in her yard with her panties over her pants. Pt already walks with a cane, but she's having more difficulty than usual walking, doesn't know where she's at nor the time. Pt does not have dementia but daughter states that's how she's acting. She called the pharmacy and was told delirium can be a side effect to the shots and was advised to call here.     Instructed daughter to take patient to ED at Medical Center as this was unexpected. Had extensive workup for altered mental status (still altered upon arrival there), which did not reveal source (only showed mild transaminitis per ED records). Slowly her mental state returned to her usual, normal baseline.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, C-reactive protein normal, Full blood count, Knee arthroplasty, Red blood cell sedimentation rate normal
Clinical narrative: Right knee pain developed 2 weeks after covid vaccine. Patient had total knee replacement in that joint in 6/2023. Subsequent testing by orthopedic surgeon (including CRP, ESR, synovial fluid analysis) negative.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Synovial fluid analysis normal
Clinical narrative: Right knee pain developed 2 weeks after covid vaccine. Patient had total knee replacement in that joint in 6/2023. Subsequent testing by orthopedic surgeon (including CRP, ESR, synovial fluid analysis) negative.
Age: 1.75
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: She started with an all over body rash 14 days after injection of MMR vaccine
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient recieved the spikevax Moderna vaccine after the use-by-date. Patient was informed and will come get a new vaccine in the next day or 2. No adverse effects were reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient recieved the spikevax Moderna vaccine after the use-by-date. Patient was informed and will come get a new vaccine in the next day or 2. No adverse effects were reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Erythema, Pain in extremity, Pyrexia
Clinical narrative: Employee went to ER the evening of vaccine with chest pain, shortness of breath,  painful red arm, fever of 101 degrees, and Ringing in ears.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Employee went to ER the evening of vaccine with chest pain, shortness of breath,  painful red arm, fever of 101 degrees, and Ringing in ears.
Age: 82.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Redness around injection site. Warm to the touch
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site pain, Mass, Mobility decreased, Pain
Clinical narrative: EMPLOYEE- who states that she just had the COVID vaccine yesterday and cannot lift arm all the way up/only can lift half way. She also states that there is a radiating pain that goes from the injection site down her arm to the fingers. She additionally mentions a lump on back of shoulder (not red, mildly painful). States the injection site is mildly red but no swelling or pain. She denies fever but has mild body aches.
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain in extremity
Clinical narrative: EMPLOYEE- who states that she just had the COVID vaccine yesterday and cannot lift arm all the way up/only can lift half way. She also states that there is a radiating pain that goes from the injection site down her arm to the fingers. She additionally mentions a lump on back of shoulder (not red, mildly painful). States the injection site is mildly red but no swelling or pain. She denies fever but has mild body aches.
Age: 45.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Cough, Fatigue, Oropharyngeal pain, Productive cough
Clinical narrative: patient experienced sore throat, fatigue, cough, phlegm.  those symptoms persisted for 5 days when the patient called us. I advised the patient to seek medical attention from his primary care provider.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Anxiety, Blood test normal, Feeling abnormal, Gait disturbance, Hyperhidrosis
Clinical narrative: She got her vaccine, didn't have any reaction at the beginning.  Then about 8:00 is when she started getting the reaction.  It felt like a car was on top of her body, she could not move, could not walk was taking baby steps.  She was very anxious, her heart was palpitating, and just felt weird like something wasn't right, and was very nervous.  Was also sweating a lot too.  She called the Advice nurse and was told to go to the ER.  She went to the ER, and they told her that sometimes people have really bad reactions to the shingles vaccine, and they gave her something to take.  She took the medicine orally and then they gave her some Ativan for her anxiety.  This did not help really much, and was discharged from the ER.  They did blood work and everything came back on  her and that it was probably just a reaction to the vaccine.  Everyday it is getting better, and today she says that she feels good.  She is not having any symptoms at all right now.    She states that she will never get any type of vaccine as long as she lives as she felt like she was dying.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Immunisation reaction, Mobility decreased, Nervousness, Palpitations
Clinical narrative: She got her vaccine, didn't have any reaction at the beginning.  Then about 8:00 is when she started getting the reaction.  It felt like a car was on top of her body, she could not move, could not walk was taking baby steps.  She was very anxious, her heart was palpitating, and just felt weird like something wasn't right, and was very nervous.  Was also sweating a lot too.  She called the Advice nurse and was told to go to the ER.  She went to the ER, and they told her that sometimes people have really bad reactions to the shingles vaccine, and they gave her something to take.  She took the medicine orally and then they gave her some Ativan for her anxiety.  This did not help really much, and was discharged from the ER.  They did blood work and everything came back on  her and that it was probably just a reaction to the vaccine.  Everyday it is getting better, and today she says that she feels good.  She is not having any symptoms at all right now.    She states that she will never get any type of vaccine as long as she lives as she felt like she was dying.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone, Condition aggravated, Electric shock sensation, Full blood count, Laboratory test
Clinical narrative: Neuropathy in feet started abruptly after 3 dose of vaccine. Asked if this could be vaccine related and physicians were unsure. This recent vaccine booster given and neuropathy symptoms started in my arms and hands bilaterally. Bee stings, lightning shock pains in my fingers.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test, Neuropathy peripheral, Pain, Vitamin B12, Vitamin D
Clinical narrative: Neuropathy in feet started abruptly after 3 dose of vaccine. Asked if this could be vaccine related and physicians were unsure. This recent vaccine booster given and neuropathy symptoms started in my arms and hands bilaterally. Bee stings, lightning shock pains in my fingers.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: pt received covid vaccine 6m-4y dosage instead of 5y-11y dosage. incorrect vial chosen in med room.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Disorientation, Fatigue, Loss of consciousness, Syncope, Vomiting
Clinical narrative: PT CAME IN WITH HIS MOTHER TO RECEIVE THE COVID AND FLU SHOT. WHEN THE VACCINE WAS ALREADY ADMINISTERED AND WAS DISPOSING THE SYRINGE IN THE SHARPS CONATAINER, THE PATIENT FAINTED. MOTHER, BROTHER, AND PHARMACIST MADE SURE HE DID NOT HIT HIS HEAD AND WAS UNCONSIOUSNESS FOR ABOUT A MINUTE TO TWO MINUTES. PT CAME BACK AND HE STATED THAT HE WAS DISORIENTED FOR FEW SECONDS. AFTER COUPLE OF MINUTES OF REGAINING CONSCIOUSNESS PHARMACIST GAVE HIM THE TRASH CAN AS HE THREW UP A LITTLE. AFTER 15 MINUTES OF OBSERVATION (PT WAS SITTING AND HANDED HIM A WATER BOTTLE), PT WAS WALKING AROUND AND CAME BACK TO NORMAL STATE. PHARMACIST CALLED 11/21/2023 TO PARENTS TO FOLLOW UP AND THEY STATED THAT HE FELT LITTLE FATIGUE AFTER GOING BACK HOME BUT EVERYTHING ELSE HE FELT FINE AND OKAY.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: pt received incorrect dosage of covid vaccine. Received 6m-4y dosage instead of 5y-11y dosage. Incorrect vial chosen in med room by RN.
Age: 16.0
Sex: F
Vaccine: MNQ, PNC20
Symptoms: No adverse event, Wrong product administered
Clinical narrative: The patient was given Prevnar 20 in error. MD was notified, no adverse effects or symptoms were observed or reported by patient.  The correct vaccine ordered by MD was then given (Menquadfi) No adverse effects or symptoms were observed or reported by patient.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: 17 yo emancipated minor, female received 1/2 the correct dose, she received the dose intended for age 6 mo to 11 yo. She was immediately informed and to return to clinic.  Patient declined returning to clinic to receive the second half of the correct dose.
Age: 85.0
Sex: F
Vaccine: RSV, VARZOS
Symptoms: Delirium
Clinical narrative: Pt was delirious in nursing home after administration- went away after visit to ER
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Arteriogram coronary abnormal, Catheterisation cardiac abnormal, Coronary arterial stent insertion, Percutaneous coronary intervention
Clinical narrative: STEMI requiring hospitalization and cardiac catheterization with stenting on 09/14/2023 around 2-3 weeks after vaccine adminstered.
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Troponin
Clinical narrative: STEMI requiring hospitalization and cardiac catheterization with stenting on 09/14/2023 around 2-3 weeks after vaccine adminstered.
Age: 62.0
Sex: M
Vaccine: RSV
Symptoms: Fatigue, Headache, Irritability, Night sweats, Pain
Clinical narrative: He got his vaccine, the next morning when he woke up and he had some body aches, had some night sweats, and was incredibly congested and still is.  He was real irritable as well.  He also had some fatigue.  He took some Tylenol as he had a headache as well, and took some nasal spray to help with the congestion.  He is othewise improving.
Age: 62.0
Sex: M
Vaccine: RSV
Symptoms: Respiratory tract congestion
Clinical narrative: He got his vaccine, the next morning when he woke up and he had some body aches, had some night sweats, and was incredibly congested and still is.  He was real irritable as well.  He also had some fatigue.  He took some Tylenol as he had a headache as well, and took some nasal spray to help with the congestion.  He is othewise improving.
Age: 63.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: At the vaccination clinic where 70 vaccines were administered, this patient was administered the influenza vaccine after informed that we had administered it together with the pneumococcus vaccine, without informing us that she had already received the flu vaccine during the month of September 2023. According to CDC guidelines, only one dose should be administered per season and in this patient, it was administered a second time. The patient has had no adverse effects.
Age: 34.0
Sex: F
Vaccine: COVID19, FLU4, HEPA
Symptoms: Underdose
Clinical narrative: Pt received a pediatric dose of hep A vaccine, as opposed to the adult dosage. No problem s/s were observed or reported. Pt came received the correct adult dosage Hep A vaccine 11/20/2023.
Age: 33.0
Sex: M
Vaccine: UNK
Symptoms: Cold sweat, Headache, Nausea
Clinical narrative: Donor states about an hour and a half to two hours after immunization was given started feeling nauseas, clammy with a headache. After s/s arised donor states had a meal and s/s resolved.
Age: 16.0
Sex: F
Vaccine: HPV9, IPV, MMR, VARCEL
Symptoms: Extra dose administered
Clinical narrative: patient inadvertently received HPV VAR MMR and polio vaccine
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 1st dose of Shingrix was 10/05/2023; 2nd dose given 11/21/2023 approx 1 1/2 weeks too soon.
Age: 1.25
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Speech disorder
Clinical narrative: Speech regression
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Postmenopausal haemorrhage, Vaginal haemorrhage
Clinical narrative: Vaginal bleeding after menopause
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Contusion, Gait inability, X-ray
Clinical narrative: After 24 hours sever ankle pain and unable to put weight on that leg,   This occurred  on Oct 25.   Received the RSV injection on Oct 31 and the pain return and could not walk on the foot again.   About three weeks later after driving about 30 minutes, exited my car and again I could not walk on it.   There is brusing on the  bread toe and two toes next to the great toe, which migrated to the bottom of my foot and then up the inside of my ankle to the shin.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Fall
Clinical narrative: The patient was brought to the ED by EMS  on 10/17/23 for evaluation of weakness and after a fall. In the ED he had a fever of 101.4 F. O2 sats were at 87% so patient was placed supplemental O2. A COVID PCR test resulted positive while the patient was in the ED. Ultimately, the patient was admitted 10/17/23 - 10/20/23 with discharge diagnoses including acute hypoxic respiratory failure due to COVID 19 pneumonia and suspected superimposed bacterial pneumonia, among other diagnoses. During admission, the patient was able to be weaned off oxygen.   The patient has received the Pfizer Monovalent COVID vaccine (given 2/19/21; 3/11/21; 12/6/21) and the Pfizer Bivalent COVID vaccine (given 2/4/23).
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pneumonia bacterial, Pyrexia, SARS-CoV-2 test positive, Superinfection
Clinical narrative: The patient was brought to the ED by EMS  on 10/17/23 for evaluation of weakness and after a fall. In the ED he had a fever of 101.4 F. O2 sats were at 87% so patient was placed supplemental O2. A COVID PCR test resulted positive while the patient was in the ED. Ultimately, the patient was admitted 10/17/23 - 10/20/23 with discharge diagnoses including acute hypoxic respiratory failure due to COVID 19 pneumonia and suspected superimposed bacterial pneumonia, among other diagnoses. During admission, the patient was able to be weaned off oxygen.   The patient has received the Pfizer Monovalent COVID vaccine (given 2/19/21; 3/11/21; 12/6/21) and the Pfizer Bivalent COVID vaccine (given 2/4/23).
Age: 52.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Muscular weakness
Clinical narrative: Workforce member reports increasing pain and weakness in my arm at the injection site since  flu vaccine. Increasing pain and weakness.
Age: 14.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Syncope
Clinical narrative: Patient fainted twice after second vaccine administered. Patient's Mom stated after the fact that the patient has fainted after vaccines in the past but did not disclose that information prior to because she thought her daughter had "grown out of it".
Age: 19.0
Sex: F
Vaccine: HPV9
Symptoms: Cardiac monitoring, Echocardiogram, Fatigue, Headache, Postural orthostatic tachycardia syndrome
Clinical narrative: After recieving the injection within the next couple of months; experienced fatigue, presyncope, syncope and headaches. Visited cardiologist to address concerns and symptoms. Later diagnosed with POTS on 12/27/2023 after enduring a tilt table test, and echo and wearing a heart monitor.
Age: 19.0
Sex: F
Vaccine: HPV9
Symptoms: Presyncope, Syncope, Tilt table test positive
Clinical narrative: After recieving the injection within the next couple of months; experienced fatigue, presyncope, syncope and headaches. Visited cardiologist to address concerns and symptoms. Later diagnosed with POTS on 12/27/2023 after enduring a tilt table test, and echo and wearing a heart monitor.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hyperhidrosis
Clinical narrative: About 5 min after vaccine was given patient reported difficulty breathing and stated that this is what happened last time he had a reaction to a vaccine. Patient taken back to an exam room, diaphoretic and reporting difficulty breathing. Epi pen given, 911 called, EMS on scene 2 min after being called, assessed patient and cleared patient to be transported to ER privately, instead of by EMS. Patient wheeled to ER.
Age: 80.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Pt received a Flu vaccine on 11/20/23 at our clinic at 3:30PM. Later her spouse called and stated that she had already received a flu vaccine on 09/14/23 at a different clinic. NO adverse reactions or symptoms
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Patient uncooperative, Underdose
Clinical narrative: Was giving patient the MMR vaccine in left upper arm and patient had moved vaccine had come out of his arm, and only half the dose was administered. Did speak with RN in office and she spoke with mom and mom was agreeable to patient getting another MMR vaccine today 11/21/23 since the half dose is an invalid dose. Dr. also spoke with patient's mother.
Age: 56.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site nerve damage
Clinical narrative: The injection hit a nerve in my shoulder that runs into my index finer and middle finger. I am still feeling it today 11/21/2023.